Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43

Paula Castellanos Otero,Tiffany W. Todd,Wei Shao,Caroline J. Jones,Kexin Huang,Lillian M. Daughrity,Mei Yue,Udit Sheth,Tania F. Gendron,Mercedes Prudencio,Björn Oskarsson,Dennis W. Dickson,Leonard Petrucelli,Yong-Jie Zhang
DOI: https://doi.org/10.1371/journal.pone.0298080
IF: 3.7
2024-04-18
PLoS ONE
Abstract:Inclusions containing TAR DNA binding protein 43 (TDP-43) are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). One of the disease-specific features of TDP-43 inclusions is the aberrant phosphorylation of TDP-43 at serines 409/410 (pS409/410). Here, we developed rabbit monoclonal antibodies (mAbs) that specifically detect pS409/410-TDP-43 in multiple model systems and FTD/ALS patient samples. Specifically, we identified three mAbs (26H10, 2E9 and 23A1) from spleen B cell clones that exhibit high specificity and sensitivity to pS409/410-TDP-43 peptides in an ELISA assay. Biochemical analyses revealed that pS409/410 of recombinant TDP-43 and of exogenous 25 kDa TDP-43 C-terminal fragments in cultured HEK293T cells are detected by all three mAbs. Moreover, the mAbs detect pS409/410-positive TDP-43 inclusions in the brains of FTD/ALS patients and mouse models of TDP-43 proteinopathy by immunohistochemistry. Our findings indicate that these mAbs are a valuable resource for investigating TDP-43 pathology both in vitro and in vivo .
multidisciplinary sciences
What problem does this paper attempt to address?